Véronique Quillien

Inserm — France

Medicine · Health Sciences

31h-index3.8kcitations132works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(51), Epigenetics and DNA Methylation(18), Immunotherapy and Immune Responses(15), Cancer Genomics and Diagnostics(14), CAR-T cell therapy research(10)

Publications132 total

Plasma‐based analysis of <i>ERBB2</i> mutational status by multiplex digital <scp>PCR</scp> in a large series of patients with metastatic breast cancer
Molecular Oncology·2024· 8 citedOpen Access
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma
Neuro-Oncology·2023· 15 citedOpen Access
Author response for "Plasma‐based analysis of &lt;i&gt;ERBB2&lt;/i&gt; mutational status by multiplex digital &lt;scp&gt;PCR&lt;/scp&gt; in a large series of patients with metastatic breast cancer"
2023
Table of Contents
ESMO Open·2023Open Access
Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma
ESMO Open·2023· 4 citedOpen Access
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients
Clinica Chimica Acta·2023· 9 citedOpen Access
Abstract 2314: Development of a 6-color multiplex Crystal Digital PCR assay for the detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients
Cancer Research·2023
Supplementary Materials and Methods, Supplementary Figures 1-7, Supplementary Tables 1-2 from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Supplementary Data from A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
2023Open Access
Data from A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1-7, Supplementary Tables 1-2 from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Data from A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
2023Open Access
Data from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Supplementary Data from A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
2023Open Access
Data from CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2023Open Access
Dual <scp>IRE1 RNase</scp> functions dictate glioblastoma development
EMBO Molecular Medicine·2023· 7 citedOpen Access
Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers
Advances in Radiation Oncology·2022· 16 citedOpen Access
144P Development of a 6-color multiplex crystal digital PCR assay for the simultaneous detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients
Annals of Oncology·2022Open Access
Prognostic value of hPG<sub>80</sub> (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.
Journal of Clinical Oncology·2022· 2 cited
Dual IRE1 RNase functions dictate glioblastoma development
EMBO Molecular Medicine·2022· 15 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Tony Avril(19), Jean Mosser(18), Élodie Vauléon(13), Amandine Etcheverry(12), Stéphan Saïkali(10), Abderrahmane Hamlat(9), Marc Aubry(8), Marie de Tayrac(8), Alain Carpentier(7), Éric Chevet(7), A Daver(6), Philippe Meneï(6), Lucie Karayan‐Tapon(6), Dominique Figarella‐Branger(6), Pierre‐Jean Le Reste(6), Louis Toujas(6), Gabriel Ricolleau(5), Philippe Broët(5), Rachel Boniface(5), Thierry Lesimple(5)